Compare EOG Resources Inc (EOG) vs Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs Maravai LifeSciences Holdings Inc. Class A Common Stock — how do they compare? EOG Resources Inc trades at $155.88 (market cap $80.34B), while Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M). The key difference: EOG Resources Inc is far larger — about 82.6× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and EOG Resources Inc pays a 2.66% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days on average.
| EOG | MRVI | |
|---|---|---|
Market Cap | $80.34B | $972.90M |
Volume | 2,309,813 | 4,325,710 |
Sector | Energy | Health |
52-Week High | $154.19 | $9.00 |
52-Week Low | $101.78 | $2.83 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $83.69B | $1.08B |
Dividend Yield | 2.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $154.19, up 2.45% today, with a bullish technical outlook and strong fundamentals. The stock has beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.07 exceeding expectations. Valuation ratios are attractive, including a P/E of 11.92 and EV/EBITDA of 6.02. Recent news highlights robust operational execution and a CFO transition.
The outlook remains positive, supported by analyst consensus of a $165 price target and 59% buy ratings. Key risks include oil price volatility and capital expenditure trends. Upside potential hinges on sustained earnings growth and disciplined capital allocation amid energy market fluctuations.
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →
